Business Description
Mochida Pharmaceutical Co Ltd
NAICS : 325412
ISIN : JP3922800002
Share Class Description:
FRA:MFY: Ordinary SharesDescription
Mochida Pharmaceutical Co Ltd is a major drug manufacturing company that operates in the field of medical care through its pharmaceuticals, healthcare products, and medical equipment businesses. The company's pharmaceuticals business aims to develop and market a broad spectrum of innovative new drugs. One of Mochida's main objectives is to maximize the business performance of its drugs after they are developed and released. The company also creates skin care products for the general public, and these are supplied through pharmacies, drugstores, and mail-order sales.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.81 | |||||
| Interest Coverage | 3942 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 4.61 | |||||
| Beneish M-Score | -2.58 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 2.2 | |||||
| 3-Year EBITDA Growth Rate | 2.2 | |||||
| 3-Year EPS without NRI Growth Rate | 0.9 | |||||
| 3-Year FCF Growth Rate | -9.9 | |||||
| 3-Year Book Growth Rate | 3.7 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 27.6 | |||||
| 9-Day RSI | 32.9 | |||||
| 14-Day RSI | 35.67 | |||||
| 6-1 Month Momentum % | -3.5 | |||||
| 12-1 Month Momentum % | -15.35 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.39 | |||||
| Quick Ratio | 3.24 | |||||
| Cash Ratio | 1.68 | |||||
| Days Inventory | 198.49 | |||||
| Days Sales Outstanding | 113.51 | |||||
| Days Payable | 74.37 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 2.69 | |||||
| Dividend Payout Ratio | 1.08 | |||||
| Forward Dividend Yield % | 2.67 | |||||
| 5-Year Yield-on-Cost % | 2.2 | |||||
| 3-Year Average Share Buyback Ratio | 1.9 | |||||
| Shareholder Yield % | 2.59 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 51.24 | |||||
| Operating Margin % | 3.94 | |||||
| Net Margin % | 3.01 | |||||
| FCF Margin % | 5.48 | |||||
| ROE % | 2.36 | |||||
| ROA % | 1.9 | |||||
| ROIC % | 2.82 | |||||
| ROC (Joel Greenblatt) % | 8.66 | |||||
| ROCE % | 3.38 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 36.66 | |||||
| PE Ratio without NRI | 38.31 | |||||
| Shiller PE Ratio | 14.44 | |||||
| PS Ratio | 1.11 | |||||
| PB Ratio | 0.86 | |||||
| Price-to-Tangible-Book | 0.86 | |||||
| Price-to-Free-Cash-Flow | 22.38 | |||||
| Price-to-Operating-Cash-Flow | 15.74 | |||||
| EV-to-EBIT | 14.98 | |||||
| EV-to-EBITDA | 14.98 | |||||
| EV-to-Revenue | 0.66 | |||||
| EV-to-FCF | 12.89 | |||||
| Price-to-Projected-FCF | 0.72 | |||||
| Price-to-Median-PS-Value | 0.71 | |||||
| Price-to-Graham-Number | 1.21 | |||||
| Price-to-Net-Current-Asset-Value | 1.32 | |||||
| Price-to-Net-Cash | 8.55 | |||||
| Earnings Yield (Greenblatt) % | 6.68 | |||||
| FCF Yield % | 4.66 | |||||
| Forward Rate of Return (Yacktman) % | -3.75 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Mochida Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 654.164 | ||
| EPS (TTM) (€) | 0.519 | ||
| Beta | 0.16 | ||
| Volatility % | 9.05 | ||
| 14-Day RSI | 35.67 | ||
| 14-Day ATR (€) | 0.13675 | ||
| 20-Day SMA (€) | 18.635 | ||
| 12-1 Month Momentum % | -15.35 | ||
| 52-Week Range (€) | 18.3 - 24.8 | ||
| Shares Outstanding (Mil) | 35.45 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Mochida Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Mochida Pharmaceutical Co Ltd Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Mochida Pharmaceutical Co Ltd Frequently Asked Questions
What is Mochida Pharmaceutical Co Ltd(FRA:MFY)'s stock price today?
The current price of FRA:MFY is €18.30. The 52 week high of FRA:MFY is €24.80 and 52 week low is €18.30.
When is next earnings date of Mochida Pharmaceutical Co Ltd(FRA:MFY)?
The next earnings date of Mochida Pharmaceutical Co Ltd(FRA:MFY) is .
Does Mochida Pharmaceutical Co Ltd(FRA:MFY) pay dividends? If so, how much?
The Dividend Yield %  of Mochida Pharmaceutical Co Ltd(FRA:MFY) is 2.69% (As of Today), Highest Dividend Payout Ratio of Mochida Pharmaceutical Co Ltd(FRA:MFY) was 1.08. The lowest was 0.28. And the median was 0.37. The  Forward Dividend Yield % of Mochida Pharmaceutical Co Ltd(FRA:MFY) is 2.67%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers